People · Operator

Kurt Andrew Frahn

Named in public records as an officer, director or promoter · active 2014–2014 · Pharmaceuticals

1
Companies
2
Filings
$115.9M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Romark Laboratories, L.C.PharmaceuticalsSeries B$115.9M$365.5M2014
Operator network

Kurt Andrew Frahn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

W. Andrew Krusen, Jr. · 4 companies · 1 sharedW. Andrew Krusen,…Brian S. Schnieders · 2 companies · 1 sharedBrian S. Schniede…Celine S. Rossignol · 2 companies · 1 sharedCeline S. Rossign…Marc S. Ayers · 2 companies · 1 sharedMarc S. AyersW. Seymour Holt · 2 companies · 1 sharedW. Seymour HoltBrian E. Schnieders · 1 companies · 1 sharedBrian E. Schniede…Brian Schnieders · 1 companies · 1 sharedBrian SchniedersCeline E. Rossignol · 1 companies · 1 sharedCeline E. Rossign…Celine Rossignol · 1 companies · 1 sharedCeline RossignolEmmet B. Keefe · 1 companies · 1 sharedEmmet B. KeefeJean Francois Rossignol · 1 companies · 1 sharedJean Francois Ros…Jeff B. Crowther · 1 companies · 1 sharedJeff B. CrowtherJeff Crowther · 1 companies · 1 sharedJeff CrowtherRomark Laboratories, L.C. · $115.9M raisedRomark Laboratories, …Kurt Andrew FrahnKF
Kurt Andrew Frahn Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Kurt Andrew Frahn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
W. Andrew Krusen, Jr.14
W. Seymour Holt12
Celine S. Rossignol12
Marc S. Ayers12
Brian S. Schnieders12
Celine Rossignol11
Jeff Crowther11
Jeff B. Crowther11
Brian Schnieders11
Emmet B. Keefe11
Jean Francois Rossignol11
Brian E. Schnieders11
Celine E. Rossignol11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.